Benefits of statins in cerebrovascular disease

Mario Di Napoli1

  • 1Neurological Section, SMDN-Center for Cardiovascular Medicine and Cerebrovascular, Disease Prevention, 41 Via Trento, I-67039-Sulmona, AQ, Italy. mariodinapoli@katamail.com

Current Opinion in Investigational Drugs (London, England : 2000)
|April 16, 2004
PubMed

Insights

Statins effectively reduce ischemic stroke risk by lowering cholesterol and preventing atherosclerosis. These cholesterol-lowering drugs also offer stroke protection through mechanisms independent of their lipid-lowering effects.

Area of Science:

  • Neurology
  • Cardiology
  • Pharmacology

Background:

  • Elevated cholesterol is linked to coronary heart disease, but its role in stroke is less clear.
  • Epidemiological data suggest high lipids correlate with ischemic stroke, while low lipids may increase hemorrhagic stroke risk.

Purpose of the Study:

  • To evaluate the impact of lipid-lowering statins on stroke incidence and outcomes.
  • To explore the mechanisms underlying statin benefits in stroke prevention.

Main Methods:

  • Review of epidemiological studies on lipid levels and stroke risk.
  • Analysis of clinical trial data on statin use and stroke events.
  • Examination of proposed mechanisms for statin effects on cerebrovascular health.

Main Results:

  • Statins reduce ischemic stroke incidence without increasing hemorrhagic stroke frequency.
  • Statin benefits may stem from cholesterol reduction, decreased atherosclerotic plaque progression, and reduced emboli.
  • Potential cholesterol-independent effects include improved cerebral blood flow, reduced inflammation, and oxidative stress.

Conclusions:

  • Statins demonstrate significant potential in reducing stroke incidence and improving patient prognosis.
  • The multifaceted actions of statins, encompassing both lipid-dependent and independent pathways, contribute to their cerebrovascular protective effects.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...